Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Volavka J et al. - The classification of antipsychotics into the two groups is no longer useful. The treatment selection for an individual patient should focus on the suitability of an individual antipsychotic for that patient rather than on the group membership of the drug.

   

Related Articles

Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09    Relevance Score: 93%

Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09    Relevance Score: 92%

Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09    Relevance Score: 91%

Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09    Relevance Score: 91%

Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09    Relevance Score: 91%

Today in Neuro/Psych pharmacology...keeping you current

Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology, 12/15/09

An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas
Journal of Pharmacy and Pharmacology, 12/15/09

Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address